Guidelines are painted with broad strokes and cannot possibly cover complex situations that emerge in the care of people with chronic kidney disease and multiple illnesses. The authors of the recent ...

The final 2025 KDIGO Guideline suggests treatment with Nefecon should be considered in the majority of patients at risk of progressive loss of kidney function CHELMSFORD, Mass. & TOKYO, November 04, ...

Acute kidney injury (AKI) remains one of the most frequent and clinically significant complications among critically ill ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. A new set of practice guidelines aims to help transplant ...

Please provide your email address to receive an email when new articles are posted on . Amy Earley, who became KDIGO’s first guideline development director in January, has jumped into a quickly ...

Medscape Nephrology is pleased to present the Kidney Disease: Improving Global Outcomes (KDIGO) Guideline for Hepatitis C in Chronic Kidney Disease (CKD), which were presented on April 4 at the ...

AUSTIN, Texas--(BUSINESS WIRE)-- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, commented today on the 2024 Clinical Practice Guideline for the Evaluation and Management of ...

Monitoring calcium, phosphorus, PTH and alkaline phosphatase regularly and basing therapeutic decisions on trends rather than single laboratory values is the best approach to managing mineral and bone ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The new KDIGO anaemia guidelines represent a bold, sensible, and patient-centred approach to anaemia management in patients with chronic kidney disease. Recommendations regarding haemoglobin targets, ...

CAMBRIDGE, England--(BUSINESS WIRE)--As the European distributor of Invokana ® (canagliflozin) and Vokanamet ® (canagliflozin and metformin), Mundipharma welcomes the publication of the first KDIGO ...